Fennec Pharmaceuticals Inc. announced that Shubh Goel, the company's chief commercial officer, has tendered her resignation and will depart Fennec in late February 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.7 USD | +2.45% |
|
+14.33% | -40.29% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.29% | 179M | |
+20.29% | 127B | |
+24.25% | 117B | |
+25.44% | 27.67B | |
-18.52% | 20.33B | |
-15.17% | 16.79B | |
-15.91% | 15.63B | |
+12.76% | 14.84B | |
-47.10% | 14.65B | |
+57.16% | 14.43B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Shubh Goel to Depart Fennec Pharmaceuticals Inc. as Chief Commercial Officer in Late February 2022